Cardiovascular prevention: the asymptomatic high calcium score — treat the risk factors, not the scan
A cardiologist’s blunt guide for GPs: high-intensity statin, aspirin only by shared decision, tighter blood pressure, glucose and lifestyle — and why routine stress tests, repeat calcium scans, angiograms and stents do not help people without symptoms.
- Speaker
- Cardiologist (name not captured on the transcript) — main presenter (Otter “Speaker 1”), discussing preventive cardiology; refers to colleagues on “the coast” and to a colleague “Matthew” who covered statins earlier in the evening.
- Others
- Comments and questions from GPs at the table (Otter “Speaker 2” and “Unknown Speaker”; names not captured).
- Session context
- Otter title Cardiovascular Prevention Strategies · id
5InFDFaaje6-jjKwWucMv22jG3k· ~20 min (1194 s), recorded 10 March 2026 7:44 PM AEST — the same evening as the AF ablation seminar, possibly another table session of the same round-table event (not confirmed on the transcript). The recording starts mid-discussion and some passages are garbled.
Key messages for GPs
- A calcium score is not a sentence to an angiogram. In an asymptomatic patient it means: treat risk factors aggressively.
- High-intensity statin is supported; aggressive LDL lowering in high-calcium patients produced substantial benefit in trials (as stated).
- Aspirin is optional — individual, shared decision; check bleeding history first. The speaker personally does not use it for primary prevention.
- Blood pressure: tighter control; quoted target <130 (systolic) in people with diabetes. Even borderline BP contributes to plaque rupture.
- No routine stress tests, no repeat calcium scans, no stents for asymptomatic plaque. Test for symptoms, poor LV function or special occupations.
- If genuinely worried about critical left main disease, a CT coronary angiogram (CTCA) is the next step — if no critical left main lesion, go no further.
“Coronary disease is not like a cancer where you hunt it down, cut it out and cure the patient.” It is a lifetime risk reduction problem. Once calcium is present the patient has coronary artery disease — the focus shifts to risk-factor control, not to tracking the number.
The prevention plan for a high calcium score
Working from the example of an asymptomatic patient with a calcium score around 1,000, the speaker’s “preventive cardiology clinic” plan was:
1. Lipids
He endorsed high-intensity statin therapy, noting that a colleague (Matthew) had covered lipids earlier. The rationale given: event risk is high in patients with high calcium scores, and trials of aggressive LDL lowering produced substantial benefit. For targets and add-on therapy see the companion posts on cholesterol management and the dyslipidemia update.
2. Blood pressure
“Tighter control” — he quoted a target of less than 130 in people with diabetes. He acknowledged the clinic reality: patients feel dizzy or get a headache, check their BP and blame it. His reminder is that hypertension is an asymptomatic disease, and even borderline blood pressure contributes to plaque rupture.
3. Glucose, metabolic syndrome and weight
Glycaemic control in diabetes and prediabetes, metabolic syndrome management and weight loss lower the risk of plaque progression. On tirzepatide (Mounjaro), he said more data on cardiac events are expected in the next few years; benefits in heart failure and hypertension are clearer, but in his view we cannot yet tell patients that losing weight will reduce their heart-attack risk. (Speaker’s opinion; the evidence for incretin-based therapies is evolving — check current data.)
4. Lifestyle
- Exercise, avoid being sedentary, include resistance training; avoid sudden extremes (he joked about bungee jumping and half-marathons).
- He is “not a strong believer” in the Mediterranean diet label, but still recommends reducing saturated fats and ultra-processed foods — “not too much salami”.
5. Smoking
Zero smoking — and you won’t find out unless you ask.
Aspirin: a genuine shared decision
The speaker called aspirin in primary prevention “an individual choice”:
- Radiology reports may recommend aspirin when the calcium score is above ~400. “If you do it, you’re correct. If you don’t, you’re correct.”
- Personally, he does not believe it reduces mortality, morbidity or events in primary prevention, and it carries a bleeding risk. He cited a large trial in thousands of older people showing no difference in outcome for primary prevention — rendered on the transcript as the “esprit trial”, most likely ASPREE.
- If you prescribe it: check for any history of bleeding, especially GI bleeding.
- Bottom line from his slide: aspirin is not automatic; consider low-dose aspirin only when bleeding risk is low, after a shared decision.
Otter’s auto-summary lists “low-dose ezetimibe”. The underlying transcript reads “consider low dose house premium. Pleading was low” in the aspirin context — most plausibly “consider low-dose aspirin if bleeding risk is low”. Ezetimibe was not discussed in this recording.
More testing? Usually no
- Routine stress testing is not indicated in asymptomatic patients with a positive calcium score. “You’re not going to make them feel better by doing anything.” The way to help them live longer is to treat risk factors.
- Repeat calcium scans are “a complete waste of time” — even though some radiology reports suggest repeating in three years. His analogy: someone who has lived on the coast all their life has sun-damaged skin; you don’t rescan next week to see whether the sun damage has got better.
- When testing is reasonable: new symptoms (exertional breathlessness, atypical chest pain) → functional study; poor LV function; special occupations (pilots, firefighters) or someone planning marathons → lower threshold.
- Left main worry: if concerned about a silent critical left main lesion, do a CTCA; if it shows plaque but no critical left main lesion, “you don’t need to go any further”. An invasive angiogram carries procedural risk without proven outcome benefit in this setting.
Why do asymptomatic patients get angiograms and stents?
The speaker asked the uncomfortable question directly. His answer: cardiologists are “not being irrational” — but the reasons are only partly scientific.
| Driver he named | The logic | The problem |
|---|---|---|
| “Find it, fix it” model | Coronary disease = focal stenosis; high calcium must mean severe obstruction. | Calcium reflects total plaque burden, not the blockages that cause symptoms. |
| Ticking time bomb | “If we don’t look, we might miss a critical left main.” | Silent critical left main is rare; CTCA can answer the question non-invasively. |
| Anxiety relief | A visible blockage feels actionable for patient and doctor. | A clean angiogram gives false reassurance; a found lesion triggers a cascade. |
| Interventional bias | Once in the lab, “the temptation to stent is strong” (the oculostenotic reflex). | Guidelines say medical therapy is equivalent in stable, asymptomatic disease. |
| Defensive medicine | Fear of litigation if the patient has an event later. | Not evidence-based, but “culturally and financially reinforced”. |
| Money & time | More procedures, more income; explaining plaque biology is harder than ordering a test. | He was blunt that financial incentives play a part. |
What the evidence says (per the speaker)
- Most acute events occur in non-obstructive, 10–20% soft plaques that suddenly rupture — patients often had no symptoms beforehand.
- He said ~30% of people have sudden death as their first presentation of coronary artery disease.
- Revascularisation (stenting or bypass) in asymptomatic patients does not reduce myocardial infarction or mortality.
- Finding a 70% lesion does not change management: statin, BP and lifestyle targets are maximal anyway — but the angiogram adds contrast, radiation, procedural complications and downstream interventions (stents needing redo, bypass after stent failure).
A cautionary case
A man in his mid-50s, asymptomatic and cycling regularly, had a positive calcium score and was referred for CTCA, then went on to bypass surgery despite having no symptoms. The transcript suggests a bleeding complication around day three and mentions an autopsy. Details are incomplete, but the speaker’s point was clear: an asymptomatic patient sent down a cascade of tests can come to serious harm.
A GP at the table said that after two similar experiences they had stopped ordering calcium scores and moved to CTCA when anatomy was needed. The speaker’s practical advice for the result that arrives “at 10 o’clock on a Tuesday”: start or intensify the statin, think about aspirin, control the blood pressure, “keep doing what you’re doing” — no further testing if the patient is completely asymptomatic.
GP clinic checklist
- Asymptomatic + high calcium score → high-intensity statin and full risk-factor review (BP, HbA1c, weight, smoking, activity).
- BP: aim tighter (speaker quoted <130 in diabetes); remind patients hypertension is usually symptomless.
- Aspirin: discuss, don’t default. Check bleeding/GI history; document the shared decision.
- Don’t order routine stress tests or repeat calcium scans for monitoring.
- Do test when symptoms appear (functional study), with poor LV function, or for special occupations.
- Worried about left main? CTCA first; no critical lesion → no invasive angiogram.
- Spend the time on the plaque-biology conversation: “it’s not a cancer you cut out — it’s lifelong risk reduction.”